. Therefore, understanding how DCIS progresses to IDC might enable the selective treatment of those at high risk of developing IDC. A paper in Cell by Casasent et al. 6 reveals the origin of DCIS and its progression to IDC.
Casasent and colleagues obtained frozen samples of breast-cancer tissue gathered from patients. The authors used single-cell DNA sequencing of cells from DCIS and IDC regions in the same section of tissue to create molecular maps of patients' breast cancers, in an approach they call topographic single-cell sequencing. They stained the samples to identify tumour cells and noted the location of each selected cell in the regions of DCIS and IDC. A technique called laser capture microdissection enabled the separation of a selected cell from its neighbours by tracing a laser beam around the cell. This was combined with an approach termed laser catapulting, in which energy from an ultraviolet laser propels a microdissected cell into a collection tube for subsequent DNA analysis. These laser-based techniques are used in other contexts, including forensic science and studies of plant physiology In patients with multiclonal tumours, all of the individual's clones were present in both DCIS and IDC regions (Fig. 1) . This points to a model in which clones arise and evolve in the milk duct and then escape to establish IDC elsewhere in the breast, such as in regions containing stromal cells. The various clones had a wide distribution across breast tissue, with certain clones being evenly distributed between milk ducts and regions of tumour invasion, and others being enriched in either the invaded regions or the milk ducts.
The authors conducted additional analysis by sequencing the protein-coding regions of the tumour cells' DNA -detecting an average of 23 mutations per patient. This analysis confirmed that there were striking similarities between specific clones in a given patient, regardless of whether the clonal tumour cell was part of a DCIS or an IDC region. The transition from DCIS to IDC was not associated with a notable increase in the number of mutations in the clones or in the number of independent clones. A few mutations specific to DCIS or IDC regions were identified, and, although these warrant further study, the authors' main finding is the remarkable genetic similarity of a patient's tumour cells in these two distinct disease states. The observation that genomic evolution of tumour cells occurs in the milk duct before invasion proceeds suggests that a transient period of genome instability is an early event in breast-cancer initiation.
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On the trail of invasive cells in breast cancer
During breast-cancer progression, tumour cells that arise in the milk duct spread elsewhere in the breast. The origin of these invasive tumour cells is now revealed by an analysis of spatially defined single cells. Casasent and colleagues' model, in which breast cancer arises in the milk duct from a single initiating cell that gives rise to several clones in the duct that then invade the rest of the breast tissue, contrasts with two alternative models of IDC development [8] [9] [10] . The independent-lineage model 8, 9 proposes that DCIS and IDC evolve independently from different tumour-initiating cells. The other model 10 , called an evolutionary bottleneck, proposes that a single initiating cell in the milk duct gives rise to several clones, only one of which successfully escapes the milk duct to invade the rest of the tissue.
Many questions remain. What triggers the genetic alterations in the tumour-initiating cell in DCIS? Do other potential tumour-initiating cells arise at the earliest stage of the disease, of which only one gives rise to DCIS and the others are eliminated? A better understanding is needed of how tumour cells escape the milk duct through the breakdown of the duct's outer layer (the basement membrane), and how some cells from all the clones present in DCIS manage to exit the duct. 
